An interventional study of Movement to Music and Adapted Yoga in Multiple Sclerosis and Stroke, sponsored by University of Alabama at Birmingham. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-10-15.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Supportive care
This study will examine the effectiveness of two types of group exercise classes on the health and functional status in inactive adults age 18-65 with neurological conditions including Multiple Sclerosis, stroke, and spinal cord injury (SCI). Participants will be randomly assigned to one of three groups; Movement to Music, Adapted Yoga, or a waitlist group who will complete a home-based exercise intervention of either Movement to Music or Adapted Yoga.
3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.
This study's enrollment of 180 is above the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.
Browse Multiple Sclerosis studies →University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.
Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The Movement to Music classes are composed of a set of exercises tailored to the specific needs and capabilities of each target group. The class will consist of and aerobic component and a strength component performed to varying music tempos. All movements will be choreographed by qualified dance instructors.
Behavioral: Movement to Music
Yoga classes will consist of postures adapted by qualified yoga instructors who have extensive experience in disability.
Behavioral: Adapted Yoga
This group will receive biweekly newsletters on a variety of topics. At the end of this trial, they will receive a home based intervention.
Cardiorespiratory Fitness as measured by sub-maximal VO2
Submax VO2 is assessed by the six minute walk test or the six minute push test. Participants wear a portable metabolic cart while walking or pushing
Time frame: 12 weeks
Pain as measured by PROMIS Pain Interference Short Form 8a
Time frame: 12 weeks
Fatigue as measured by PROMIS Fatigue Short Form 8a
Time frame: 12 weeks
Loneliness as measured by the Three-Item Loneliness Scale
Time frame: 12 weeks
Grip Strength as measured by hand grip dynamometer
Time frame: 12 weeks
Strength as measured by Biodex System 3 Multijoint dynamometer
Upper body strength is measured using a closed chain push/pull protocol. Lower body strength is measured using the knee flexion/extension protocol.
Time frame: 12 weeks
Balance as measured by the Timed Up and Go
The Timed to Up and Go test is performed using a chair with arms. The participants stand up from the chair, walk to a mark measured three meters from the chair then return back to the seat. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling.
Time frame: 12 weeks
Balance as measured by Biodex Limits of Stability
The Limits of Stability test is performed on the Biodex SD balance machine using the limits of stability protocol created by Biodex.
Time frame: 12 weeks
Balance as measured by Repeated Chair Stands
The repeated chair stands test is performed by asking participants to stand up and sit down 5 times as fast as possible. A score of greater than or equal to 14 seconds (average) has been shown to indicate a high risk of falling.
Time frame: 12 weeks
Health Biomarkers as measured by blood analysis (insulin)
Time frame: 12 weeks
Health Biomarkers as measured by blood analysis (lipids)
Time frame: 12 weeks
Health Biomarkers as measured by blood analysis (fasting glucose)
Time frame: 12 weeks
Blood pressure
Time frame: 12 weeks
Anthropometric measurements (weight)
Time frame: 12 weeks
Circumference measurements to be reported as composite ratios (waist circumference, hip circumference, neck circumference)
Time frame: 12 weeks
Physical Function with Mobility Aid as measured by PROMIS Physical Function with Mobility Aid 455b
Time frame: 12 weeks
Anxiety as measured by PROMIS Emotional Distress-Anxiety Short Form 8a
Time frame: 12 weeks
Depression as measured by PROMIS Emotional Distress-Depression Short Form 8a
Time frame: 12 weeks
Sleep Disturbance as measured by PROMIS Sleep Disturbance Short Form 8a
Time frame: 12 weeks
Ability to participate in social roles and activities as measured by PROMIS Ability to Participate in Social Roles and Activities Short Form 8a
Time frame: 12 weeks
Nutrition Self-Efficacy as measured by the Nutrition Self-Efficacy Scale
Time frame: 12 weeks
Physical Exercise Self-Efficacy as measured by the Physical Exercise Self Efficacy Scale
Time frame: 12 weeks
PROMIS Pain Intensity Short Form
Time frame: 12 Weeks
This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alabama at Birmingham